SSIA
CVS icon

Spero-Smith Investment Advisers’s CVS Health CVS Stock Holding History

Spero-Smith Investment Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.13M Sell
23,970
-414
-2% -$39.1K 2.86% 10
2016
Q2 		$2.33M Buy
24,384
+220
+0.9% +$21.9K 2.91% 6
2016
Q1 		$2.51M Buy
24,164
+360
+2% +$35K 3.14% 5
2015
Q4 		$2.33M Sell
23,804
-489
-2% -$47.9K 2.96% 9
2015
Q3 		$2.34M Sell
24,293
-406
-2% -$42.7K 3.17% 10
2015
Q2 		$2.59M Sell
24,699
-135
-0.5% -$13.8K 2.95% 9
2015
Q1 		$2.56M Sell
24,834
-7,726
-24% -$782K 2.85% 10
2014
Q4 		$3.13M Sell
32,560
-930
-3% -$81.9K 3.57% 3
2014
Q3 		$2.67M Sell
33,490
-656
-2% -$51.7K 3.09% 9
2014
Q2 		$2.57M Sell
34,146
-855
-2% -$64.6K 2.91% 14
2014
Q1 		$2.62M Sell
35,001
-7,950
-19% -$562K 3.1% 9
2013
Q4 		$3.07M Sell
42,951
-1,438
-3% -$92.4K 3.52% 4
2013
Q3 		$2.52M Sell
44,389
-3,376
-7% -$201K 3.13% 11
2013
Q2 		$2.73M Buy
+47,765
New +$2.77M 3.39% 5

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Spero-Smith Investment Advisers's CVS Position: Q3 2016 in Review

Spero-Smith Investment Advisers reduced its CVS Health (CVS) stake by 1.7% in Q3 2016, selling an estimated $39.1K and leaving 23,970 shares worth $2.13M. The position accounts for 2.86% of the portfolio, ranked #10.

Spero-Smith Investment Advisers first reported a position in CVS in Q2 2013 and has held it in 14 quarters since. The position peaked at $3.13M in Q4 2014. 1,564 funds tracked by Wall St. Rank hold CVS as of Q3 2016.

  • Spero-Smith Investment Advisers held 23,970 shares of CVS Health worth $2.13M as of Q3 2016.
  • Spero-Smith Investment Advisers sold 414 CVS Health shares in Q3 2016, an estimated $39.1K.
  • CVS Health made up 2.86% of Spero-Smith Investment Advisers's portfolio in Q3 2016, its #10 holding.
  • Spero-Smith Investment Advisers first reported a position in CVS Health in Q2 2013 and has held it in 14 quarters since.
  • Spero-Smith Investment Advisers's CVS Health position peaked at $3.13M in Q4 2014.
  • 1,564 funds tracked by Wall St. Rank held CVS Health as of Q3 2016.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2016, filed 31 Oct 2016.